(News Bulletin 247) – The family shareholders of Boiron are preparing to launch a public takeover bid (OPA) on the pharmaceutical laboratory in order to withdraw it from the stock market, the group announced in a press release on Tuesday.
The Boiron family concert, which holds 69.9% of the capital and 78.3% of the voting rights, has reached an agreement with the investor EW Healthcare Partners and the company Boiron Développement with a view to launching an offer at 50 euros per share .
In detail, the operation would be at a price of 39.64 euros per share, in addition to an exceptional dividend of 10.36 euros per share.
Net of the amount of the dividend, the offer price represents a premium of 36% compared to the closing price of 29.14 euros last night.
In its press release, Boiron explains that its current strategy no longer requires the maintenance of a stock exchange listing, in particular given the very low liquidity of its title.
The homeopathy specialist adds that the status of unlisted company appears to him to be much more suited to the development of a group wishing to invest significantly over a long-term horizon.
For Thierry Boiron, chairman of the board of directors, the operation will allow ‘greater freedom in long-term strategic choices’.
The family shareholders plan to request the implementation of a squeeze-out if the conditions were to be met at the end of the offer.
The quotation of the title had been suspended since the end of the morning pending the publication of a press release.
Copyright (c) 2023 News Bulletin 247. All rights reserved.
I have over 8 years of experience working in the news industry. I have worked as a reporter, editor, and now managing editor at 247 News Agency. I am responsible for the day-to-day operations of the news website and overseeing all of the content that is published. I also write a column for the website, covering mostly market news.
